Endothelin-1 (ET-1) and endothelin-3 (ET-3) produced positive inotropic effects on electrically stimulated left atria and increased the frequency of spontaneously beating right atria of adult rats. The potency of the inotropic effect of ET-1 was greater than that of ET-3, but the potencies of the chronotropic effects of ET-1 and ET-3 were not significantly different. In the neonatal atria, ET-1 and ET-3 also induced positive inotropic and chronotropic responses. ET-1 and ET-3 showed weak or no cardiotonic effects on the adult ventricles, whereas they caused marked positive inotropy in the neonatal ventricles. The characteristics of binding sites for ET-1 and ET-3 were very similar between the atria and the ventricles of the rat neonate. Saturation and competition binding experiments have shown that neonatal cardiac membranes from both atria and ventricle have two distinct binding sites for endothelin, that is, a low-affinity and a high-affinity site. ET-1 was found to bind to the low-afflinity sites with a significantly lower Kd than ET-3, whereas the estimated Kd values for ET-1 and ET-3 at the high affinity sites were similar. In contrast, the binding sites in adult atria were different from those of the ventricles: only a single binding site for both ET-1 and ET-3 was detected. Adult atrial membranes, on the other hand, had two distinct binding sites similar to those of neonatal membranes. The attenuation of the cardiotonic effects of ET-1 and ET-3 in ventricular muscle during development may be attributable to the changes that occur in the population of endothelin receptor subtypes. (Circulation Research 1991;69:918-926) E ndothelin (ET) is potent vasoconstrictor peptide containing 21 amino acids, which was originally isolated from the conditioned medium of cultured endothelial cells.' Recently, genomic DNA analysis has suggested that mammals, including humans, produce three distinct members of this peptide family, namely, ET-1 (identical to the originally isolated ET), ET-2, and ET-3.2 The biological activity of ET-2 is similar to that of ET-1, whereas the activity of ET-3 is somewhat different.2-4
Endothelin-1 (ET-1) and endothelin-3 (ET-3) produced positive inotropic effects on electrically stimulated left atria and increased the frequency of spontaneously beating right atria of adult rats. The potency of the inotropic effect of ET-1 was greater than that of ET-3, but the potencies of the chronotropic effects of ET-1 and ET-3 were not significantly different. In the neonatal atria, ET-1 and ET-3 also induced positive inotropic and chronotropic responses. ET-1 and ET-3 showed weak or no cardiotonic effects on the adult ventricles, whereas they caused marked positive inotropy in the neonatal ventricles. The characteristics of binding sites for ET-1 and ET-3 were very similar between the atria and the ventricles of the rat neonate. Saturation and competition binding experiments have shown that neonatal cardiac membranes from both atria and ventricle have two distinct binding sites for endothelin, that is, a low-affinity and a high-affinity site. ET-1 was found to bind to the low-afflinity sites with a significantly lower Kd than ET-3, whereas the estimated Kd values for ET-1 and ET-3 at the high affinity sites were similar. In contrast, the binding sites in adult atria were different from those of the ventricles: only a single binding site for both ET-1 and ET-3 was detected. Adult atrial membranes, on the other hand, had two distinct binding sites similar to those of neonatal membranes. The attenuation of the cardiotonic effects of ET-1 and ET-3 in ventricular muscle during development may be attributable to the changes that occur in the population of endothelin receptor subtypes. (Circulation Research 1991;69:918-926) E ndothelin (ET) is potent vasoconstrictor peptide containing 21 amino acids, which was originally isolated from the conditioned medium of cultured endothelial cells.' Recently, genomic DNA analysis has suggested that mammals, including humans, produce three distinct members of this peptide family, namely, ET-1 (identical to the originally isolated ET), ET-2, and ET-3.2 The biological activity of ET-2 is similar to that of ET-1, whereas the activity of ET-3 is somewhat different. [2] [3] [4] Since the original report' of the vasoconstricting capabilities of ET, ET-1 has been reported to initiate a wide variety of pharmacological activities in various tissues. 5 In the heart, ET-1 produces positive inotropic and chronotropic effects.6-9 Specific binding sites for ET-1 have been identified in a variety of tissues and species, including humans.10 Binding to these sites is both saturable and temperature sensitive.
125I-ET-1 binding is competitively inhibited by unlabeled ET-1, ET-2, and ET-3 as well as sarafotoxin S6b, a chemically homologous toxin from the venom of the burrowing asp, Attractaspis engaddensis. 10 Specific binding sites for ET-1 have also been identified in rat heart." Moreover, intriguing data have been presented that suggest that ischemia is accompanied by an increase in the density of`PI-ET-1 binding sites in the rat heart.12 Many reports13-'7 have described the developmental changes in the pharmacological and biochemical properties of various bioactive substances in the heart, such as a-and 18-adrenoceptor agonists, muscarinic cholinoceptor agonists, and Ca 2 channel antagonists. Although publications concerning the Ishikawa et al Developmental Changes in Endothelin Receptors 919 actions of ET-1 on adult cardiac muscle preparations have appeared in recent years, developmental changes have not been clarified. Rats are known to be immature at birth with respect to many physiological functions; therefore, they have been used frequently as a model to study developmental physiology.
The objectives of the present study are to 1) compare two ET isoforms, ET-1 and ET-3, on the mechanical responses in the rat atria and ventricles, 2) characterize ET receptors in the rat atria and ventricles, and 3) investigate the developmental changes that occur in mechanical response and receptor binding with these two ET isoforms.
Materials and Methods

Materials
Drugs used were human ET-1 and ET-3 (Peptide Institute, Osaka, Japan); isoproterenol hydrochloride, bovine serum albumin (BSA, fraction V), and phenylmethylsulfonyl fluoride (PMSF) (Sigma Chemical Co., St. Louis, Mo.); aprotinin (Bayer, Leverkusen, FRG); chloramine T (Wako Pure Chemicals, Osaka, Japan); and MOPS (Dojin, Kumamoto, Japan). ET-1 and ET-3 were dissolved in a phosphate-buffered saline (pH 7.4) containing 0.05% BSA.
Measurement of Contraction and Beating Rate
Adult male (8- 
Membrane Preparation
For each preparation, seven to 10 hearts from the adult or 32-64 hearts from the neonate were used. The isolated heart from the adult was initially perfused through the aorta with Krebs-Ringer solution to flush out any remaining blood. Membranes were prepared according to the protocol of Kwan et a120 with some modifications. The atria (except for that portion containing the sinoatrial node) or ventricular walls were removed from the hearts and immersed in an ice-cold homogenizing buffer of 10 mM MOPS, 0.25 M sucrose, 0.1% BSA, 0.1 mM PMSF, and 100 units/ml aprotinin (pH 7.2). A homogenate of the tissue was prepared with a polytron-type homogenizer at three-fourths maximum speed for two 30-second periods. After successive centrifugation of the homogenate at 600g for 10 minutes and at 8,400g for 10 minutes, the supernatant was decanted and centrifuged at 100,000g for 60 minutes. All centrifugations were performed at 4°C. The resultant pellet was resuspended in the ice-cold homogenizing buffer. Membrane preparations were immediately used in binding assays without freezing. The protein content was determined by the method of Lowry et a121 with BSA as the standard.
Iodination of ET-] and ET-3
ET-1 or ET-3 was radioiodinated using chloramine T. Briefly, -2 nmol peptide and 1 mCi`PI-labeled sodium (Amersham Corp., Arlington Heights, Ill.) were added to 100 gl sodium phosphate buffer (PB) (0.5 M, pH 7.4). Oxidation was started at room temperature by adding 20 gl freshly prepared chloramine T solution (26 mg/10 ml PB) and stirring for 10 seconds; oxidation was stopped by adding 50 ,ul sodium metabisulfite solution (37 mg/10 ml PB). After the addition of 1 ml of 0.5% BSA solution, the reaction mixture was loaded onto a Sep-Pak C18 cartridge (Waters Associates, Milford, Mass.) and eluted with 5 ml of 0.1% trifluoroacetic acid containing 50% acetonitrile. The monoiodinated ET-1 or ET-3 was purified by reversephase high-performance liquid chromatography (4.6x250-mm Chemocosorb 5ODS-H, Chemco). The elution time of "'I-ET-3 used in the present study was identical with that of a commercially purchased (3-`PIiodotyrosyl6)ET-3 (Amersham). ET-1 and ET-3 induced concentration-dependent, positive inotropic responses in the electrically driven left atria of the adult (Figures 1 and 3C of the maximal response to isoproterenol. The halfmaximal effective concentration (EC50) of ET-1 was 0.47 nM, which was about fivefold lower than that of ET-3 (2.2 nM).
In the electrically driven adult right ventricular preparation, concentrations of ET-1 and ET-3 .300 nM caused very weak (maximum response 7-20% of that to isoproterenol) and no positive inotropic response, respectively (Figures 1 and 3B) . In contrast, in the neonatal left ventricle, both ET-1 and ET-3 caused marked positive inotropic responses ( Figures  1 and 3A) . Although the concentration-response curves for ET-1 and ET-3 in neonatal ventricles plotted in Figure 3A continue to rise for concentrations <300 nM, it was confirmed in some experiments that a higher concentration (500 nM) of either ET Figure  4B ), whereas the latter resulted in a curvilinear plot ( Figure 4D ). This was true for both the atrial and the ventricular membranes. Computer analysis of the Figure 5 . The 1251-ET-1 binding in both atria and ventricles was completely displaced by either unlabeled ET-1 or ET-3 in a concentrationdependent manner, although ET-1 was more potent than ET-3 ( Figures 5A and SC) . Unlabeled ET-1 and ET-3 also inhibited 'PI-ET-3 binding in both the atria and the ventricles. In this case, however, ET-1 and ET-3 exhibited a similar potency for displacing 12`.
ET-3 ( Figures 5B and 5D ).
Endothelin Binding on Adult Preparations
The concentration-dependent, saturable binding of 1251-ET-1 and '25P-ET-3 to the atrial and ventricular membranes from the adult are shown in Figure 6 . The results of the Scatchard analyses for radioligand binding in the adult atrial membranes are similar to those in the neonatal membranes, a linear plot for 1251-ET-1 binding and a curvilinear plot for 125I-ET-3 (Table 1) .
Competition experiments demonstrated that 125I-ET-1 binding to the adult atrial and ventricular membranes could be completely displaced by both unlabeled ET-1 and ET-3. '251-ET-3 binding was also completely displaced by both ET-1 and ET-3 (data not shown). The displacing activities of ET-1 for both '251-ET-1 and 125I-ET-3 binding sites were more potent than those of ET-3 in both preparations. Discussion Several studies6-9 have demonstrated that ET-1 induces positive chronotropic and inotropic responses in isolated atrial preparations. The present studies indicate that not only ET-1 but also ET-3 exerts positive inotropic and chronotropic effects on the rat atria. The inotropic action of ET-3 was less potent than that of ET-1, whereas the chronotropic action of ET-3 was equipotent to that of ET-1, suggesting the possibility that the ET receptor mediating the chronotropic response is different from that mediating the inotropic response. The inotropic response to ET-1 in the ventricles of the adult rat was also observed, but it was weak compared with that in the atria, which is in agreement with the previous studies in rats and humans.8 '9 No inotropic effect of ET-3 was observed in the adult rat ventricles.
ET-1 and ET-3 also exhibited positive inotropic and chronotropic effects on the neonatal right atria. The chronotropic response in atria did not change during development; that is, the potencies of ET-1 and ET-3 in both the neonate and the adult were very similar, and the effective concentration ranges in the neonate were almost equal to those in the adult. These results suggest that ET-1 and ET-3 bind with similar affinity to ET receptors that mediate the chronotropic response and that these receptors change little with development. The sinoatrial node (which initiates the chronotropic response in the intact tissue) was not included in membrane preparations in the present study; thus, the results of binding experiments do not provide any direct evidence with respect to the receptor responsible for the chronotropic actions of ET-1 and ET-3 in the isolated right atria. EET-3 7 6 ET-1 \\ ET-3
w -w -w -w - T-3, we found evidence for only one site in the adult ventricle. Furthermore, there was a much greater reduction in the amount of binding sites for ET during development in ventricles than in atria. Thus, all these data taken together suggest that the decline of the positive inotropic effect of ETs in the ventricles during development is the result of changes in the characteristics of ET receptors.
